drugset / Trial / NCT02616250
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM) associated with Brimonidine 0.33% gel (Br) compared with the association of their respective vehicles in the treatment of moderate to severe rosacea.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 0.33 % | Topical |
| Subject | Ivermectin | Small molecule | 1 % | Topical |